News

Independent pharmacies play a significant role in delivering prescription medicines to Americans across the country, representing 35% of all retail pharmacies in the U.S.   In recent years, there has been an alarming and continuing rate of independent pharmacy closures - nea rly one in three pharmacies have closed since 2010, leaving almost 800 ZIP codes that had at least one pharmacy in 2015 now having none.   A primary factor behind the decline of independent pharmacies

By Mark Blum, Managing Director, PBM Accountability Project The insurance carrier Cigna’s Evernorth division issued a recent announcement that its pharmacy benefit manager ( PBM) Express Scripts will stop collecting manufacturer rebates in 2028. The announcement was the PBM equivalent of a head fake in football, an all-too-common deflection tactic well-known to those who have tracked the PBM industry since inception. The insurance company that owns Express Scripts wants poli

California’s SB 41 is a major win for PBM accountability, passing the legislature with broad bipartisan support and earning Governor Newsom’s signature this month.  This legislation is one of the strongest protections to date against anti-consumer PBM practices and includes important provisions to: require PBMs in California to be licensed and subject to oversight, ending their near-total lack of regulation in the state ban spread pricing – the practice where PBMs charge ins

As Congress prepares for the final legislative push of 2025, a new report from the Congressional Budget Office (CBO) reinforces the need...

As Congress returns this fall, there are likely several items on their “To Do” list – addressing healthcare costs should be near the very...

Hospitals and clinics in the 340B program often use pharmacy benefit manager (PBM) affiliated or owned contract pharmacies to dispense...

Respondents support policies to require pharmacy benefit managers (PBM)s to provide value, lower patient drug costs Carson City, NV  – As...

By: Claire Sachs, Founder of the Patient Advocate’s Chronicle and a  DPAC Champion Corps member Millions of Americans afflicted with...

The Senate Judiciary Committee held a hearing this week titled, “PBM Power Play: Examining Competition Issues in the Prescription Drug...

A recent report found that the dominance of pharmacy benefit managers (PBMs) in the 340B drug pricing program benefits these large...

In today’s healthcare landscape, few issues affect patient access and affordability as much as PBM practices. With 80% of the PBM market...

Millions of rural Americans face a devastating health crisis. They suffer from high rates of chronic diseases yet face a severe shortage...

Recent public financial disclosures from major health insurance conglomerates like CVS Health  have shed light on a concerning trend: the...

Last week, the House Energy and Commerce Committee’s Subcommittee on Health held a hearing entitled, “An Examination of How Reining in...

One employer was paying about $100 for a prescription for a generic antidepressant, though it could be bought elsewhere for about $12 A...

The New York Times  has published a detailed investigation  into how middlemen pharmacy benefit managers (PBMs) drive up drug costs for...

This is Part 1 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug pricing. Watch here >